391 related articles for article (PubMed ID: 16028170)
1. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
Munoz-Price LS; Lolans K; Quinn JP
Clin Infect Dis; 2005 Aug; 41(4):565-6. PubMed ID: 16028170
[No Abstract] [Full Text] [Related]
2. Daptomycin for the treatment of vancomycin-resistant enterococcal infections.
Grim SA; Hong I; Freeman J; Edwards C; Clark NM
J Antimicrob Chemother; 2009 Feb; 63(2):414-6. PubMed ID: 19015143
[No Abstract] [Full Text] [Related]
3. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
4. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
[No Abstract] [Full Text] [Related]
5. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
6. [Enterococcus faecalis endocarditis successfully treated with daptomycin].
Bonnet E
Med Mal Infect; 2008 Dec; 38 Spec No 2():4-6. PubMed ID: 19185201
[No Abstract] [Full Text] [Related]
7. Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report.
Kanafani ZA; Federspiel JJ; Fowler VG
Scand J Infect Dis; 2007; 39(1):75-7. PubMed ID: 17366018
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
9. Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans.
Green MR; Anasetti C; Sandin RL; Rolfe NE; Greene JN
J Oncol Pharm Pract; 2006 Sep; 12(3):179-81. PubMed ID: 17022872
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
11. [Bacteremia caused by vancomycin-resistant Enterococcus faecalis. Report of 2 cases].
Ortega L; Lite J; Garau J
Enferm Infecc Microbiol Clin; 1991 Nov; 9(9):547-50. PubMed ID: 1668361
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis.
Hidron AI; Schuetz AN; Nolte FS; Gould CV; Osborn MK
J Antimicrob Chemother; 2008 Jun; 61(6):1394-6. PubMed ID: 18344547
[No Abstract] [Full Text] [Related]
13. [Daptomycin. Reassessment of an antibiotic].
Gobernado M
Rev Esp Quimioter; 2007 Mar; 20(1):11-8. PubMed ID: 17530032
[No Abstract] [Full Text] [Related]
14. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections.
Fisher L; North D
Int J Antimicrob Agents; 2009 May; 33(5):493-4. PubMed ID: 19153034
[No Abstract] [Full Text] [Related]
16. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
Lundstrom TS; Sobel JD
Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
[TBL] [Abstract][Full Text] [Related]
17. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with daptomycin: bacteraemia and endocarditis.
Levine DP
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
Steenbergen JN; Alder J; Thorne GM; Tally FP
J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
